Aktie A144DQ MANGALAM DRUGS & ORGANICS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Mangalam Drugs & Organics Limited

Aktien

A144DQ

INE584F01014

MANGALAM

Verzögert Bombay S.E.
Andere Börsenplätze
 09:43:05 26.06.2024 		% 5 Tage % 1. Jan.
107 INR +0,05 % Intraday Chart für Mangalam Drugs & Organics Limited -0,65 % +8,92 %
13.02. Mangalam Drugs & Organics Limited meldet Gewinnergebnisse für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI
2023 Mangalam Drugs & Organics Limited berichtet über die Ergebnisse für das Halbjahr bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Mangalam Drugs & Organics Limited agreed to acquire Shri JB Pharma LLP.
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Mangalam Drugs & Organics Limited Announces Appointment of Shri Rakesh K. Milwani as an Additional Director (Non- Executive Non- Independent Director)
Mangalam Drugs & Organics : Resignation
Mangalam Drugs & Organics Limited Announces Executive Changes
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Mangalam Drugs & Organics Limited Announces Earnings Results for the First Quarter Ended June 30, 2021
Mangalam Drugs & Organics : and Organics Commissions New Manufacturing Facility in Gujarat, India
Mangalam Drugs & Organics Limited Provides Update on Setting-Up of New Intermediate Manufacturing Facility At Unit 1 Located in Vapi, Gujarat
Mangalam Drugs & Organics' : Net Profit Plummets in Fiscal Q4; Shares Plunge 8%
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A144DQ Aktie
  4. Nachrichten Mangalam Drugs & Organics Limited
  5. Andere Sprachen